COLL vs CSGP · P/E 17, rev $181.9M vs P/E 484, rev $2.74B
Collegium Pharmaceutical Inc (COLL) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the COLL and CSGP stock pages for the full models.
Not investment advice.